Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome

Leukemia Research

Volumn 34, Issue 11, 2010, Pages

  Zhou, Lili ^a   Fu, Weijun ^a   Yuan, Zhengang ^a   Hou, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CD3 ANTIGEN; CD45RO ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYBRID PROTEIN; MYELOPEROXIDASE; PROTEIN CEP110; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; BLAST CELL; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHROMOSOME 8P; DOSE RESPONSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ECHOGRAPHY; EOSINOPHILIA MYALGIA SYNDROME; EXON; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XX; LETTER; LEUKOCYTE DIFFERENTIAL COUNT; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHOCYTIC INFILTRATION; OUTCOME ASSESSMENT; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; THROAT DISEASE; CHROMOSOME 8; CHROMOSOME ANALYSIS; GENETICS; MYELOPROLIFERATIVE DISORDERS; PROCEDURES; REMISSION;

ADULT; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; INTERFERON-ALPHA; MYELOPROLIFERATIVE DISORDERS; REMISSION INDUCTION;

EID: 77957019372     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.06.027     Document Type: Letter

References (8)

1. Park T.S., Song J., Kim J.S., et al. 8p11 myeloproliferative syndrome preceded by t (8; 9) (p11; q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Cancer Genet Cytogene 2008, 181(2):93-99.
2. Zhang W.W., Habeebu S., Sheehan A.M., et al. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. J Pediatr Hematol Oncol 2009, 31(11):879-883.
3. Goradia A., Bayerl M., Cornfield D. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report. Int J Clin Exp Pathol 2008, 1(5):448-456.
4. Sahin F., Sercan Z., Ertan Y., et al. Rapid transformation of atypical myeloproliferative disorder with consistent t (8; 13) to B-cell acute lymphoblastic leukemia: a case report. Hematology 2007, 12(6):489-492.
5. JabbarAl-Obaidi M., Rymes N., White P., et al. A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report. Acta Haematol 2002, 107(2):98-100.
6. Martinez-Climent J.A., Vizcarra E., Benet I., et al. Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia. T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia 1998, 12(6):999-1000.
7. Soler G., Nusbaum S., Varet B., et al. LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia 2009, 23(7):1359-1361.
8. Invernizzi R., Benatti C., Travaglino E., et al. A further case of myeloproliferative syndrome with reciprocal translocation (8; 13)(p11;q12). Haematologica 2004, 89(2):239-241.